Potential use of angiotensin receptor blockers in skin pathologies

Renin-angiotensin system (RAS) components such as angiotensin II, angiotensin receptors (AT1R and AT2R), and angiotensin-converting enzyme (ACE) are expressed in different cell types of the skin. Through AT1R, angiotensin II increases proinflammatory cytokines contributing to fibrosis, angiogenesis,...

Full description

Bibliographic Details
Main Authors: Keshvad Hedayatyanfard, Azadeh Khalili, Hosein Karim, Soren Nooraei, Ehsan Khosravi, Nazgol Sadat Haddadi, Ahmad Reza Dehpour, Gholamreza Bayat
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2023-07-01
Series:Iranian Journal of Basic Medical Sciences
Subjects:
Online Access:https://ijbms.mums.ac.ir/article_21929_06b00c767ebd88266c0ea5ec31641aef.pdf
_version_ 1797682660748820480
author Keshvad Hedayatyanfard
Azadeh Khalili
Hosein Karim
Soren Nooraei
Ehsan Khosravi
Nazgol Sadat Haddadi
Ahmad Reza Dehpour
Gholamreza Bayat
author_facet Keshvad Hedayatyanfard
Azadeh Khalili
Hosein Karim
Soren Nooraei
Ehsan Khosravi
Nazgol Sadat Haddadi
Ahmad Reza Dehpour
Gholamreza Bayat
author_sort Keshvad Hedayatyanfard
collection DOAJ
description Renin-angiotensin system (RAS) components such as angiotensin II, angiotensin receptors (AT1R and AT2R), and angiotensin-converting enzyme (ACE) are expressed in different cell types of the skin. Through AT1R, angiotensin II increases proinflammatory cytokines contributing to fibrosis, angiogenesis, proliferation, and migration of immune cells to the skin. In contrast, AT2R suppresses the effects mentioned above. Many studies show that angiotensin receptor blockers (ARBs) and angiotensin-converting enzymes (ACEi) reduce the proinflammatory cytokines and fibrogenic factors including transforming growth factor β (TGF-β), Connective tissue growth factor (CTGF), and IL-6. This review article provides a detailed research study on the implications of ARBs in wound healing, hypertrophic scar, and keloids. We further discuss the therapeutic potentials of ARBs in autoimmune and autoinflammatory skin diseases and cancer, given their anti-fibrotic and anti-inflammatory effects.
first_indexed 2024-03-12T00:03:49Z
format Article
id doaj.art-1130e22bf94e45b29eef38083262d813
institution Directory Open Access Journal
issn 2008-3866
2008-3874
language English
last_indexed 2024-03-12T00:03:49Z
publishDate 2023-07-01
publisher Mashhad University of Medical Sciences
record_format Article
series Iranian Journal of Basic Medical Sciences
spelling doaj.art-1130e22bf94e45b29eef38083262d8132023-09-17T06:58:07ZengMashhad University of Medical SciencesIranian Journal of Basic Medical Sciences2008-38662008-38742023-07-0126773273710.22038/ijbms.2023.66563.1460621929Potential use of angiotensin receptor blockers in skin pathologiesKeshvad Hedayatyanfard0Azadeh Khalili1Hosein Karim2Soren Nooraei3Ehsan Khosravi4Nazgol Sadat Haddadi5Ahmad Reza Dehpour6Gholamreza Bayat7Department of Physiology, Pharmacology and Medical Physic, School of Medicine, Alborz University of Medical Sciences, Karaj, IranDepartment of Physiology, Pharmacology and Medical Physic, School of Medicine, Alborz University of Medical Sciences, Karaj, IranCardiovascular Research Center, Alborz University of Medical Sciences, Karaj, IranStudent of School of Veterinary Medicine, Faculty of Veterinary Medicine, University of Shahrekord, Shahrekord, IranDepartment of Veterinary Surgery, Science and Research Branch, Islamic Azad University, Tehran, IranDepartment of Dermatology, University of Massachusetts School of Medicine, Worchester, MA, USADepartment of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Physiology, Pharmacology and Medical Physic, School of Medicine, Alborz University of Medical Sciences, Karaj, IranRenin-angiotensin system (RAS) components such as angiotensin II, angiotensin receptors (AT1R and AT2R), and angiotensin-converting enzyme (ACE) are expressed in different cell types of the skin. Through AT1R, angiotensin II increases proinflammatory cytokines contributing to fibrosis, angiogenesis, proliferation, and migration of immune cells to the skin. In contrast, AT2R suppresses the effects mentioned above. Many studies show that angiotensin receptor blockers (ARBs) and angiotensin-converting enzymes (ACEi) reduce the proinflammatory cytokines and fibrogenic factors including transforming growth factor β (TGF-β), Connective tissue growth factor (CTGF), and IL-6. This review article provides a detailed research study on the implications of ARBs in wound healing, hypertrophic scar, and keloids. We further discuss the therapeutic potentials of ARBs in autoimmune and autoinflammatory skin diseases and cancer, given their anti-fibrotic and anti-inflammatory effects.https://ijbms.mums.ac.ir/article_21929_06b00c767ebd88266c0ea5ec31641aef.pdfangiotensin iicancerkeloidscarskin diseasewound healing
spellingShingle Keshvad Hedayatyanfard
Azadeh Khalili
Hosein Karim
Soren Nooraei
Ehsan Khosravi
Nazgol Sadat Haddadi
Ahmad Reza Dehpour
Gholamreza Bayat
Potential use of angiotensin receptor blockers in skin pathologies
Iranian Journal of Basic Medical Sciences
angiotensin ii
cancer
keloid
scar
skin disease
wound healing
title Potential use of angiotensin receptor blockers in skin pathologies
title_full Potential use of angiotensin receptor blockers in skin pathologies
title_fullStr Potential use of angiotensin receptor blockers in skin pathologies
title_full_unstemmed Potential use of angiotensin receptor blockers in skin pathologies
title_short Potential use of angiotensin receptor blockers in skin pathologies
title_sort potential use of angiotensin receptor blockers in skin pathologies
topic angiotensin ii
cancer
keloid
scar
skin disease
wound healing
url https://ijbms.mums.ac.ir/article_21929_06b00c767ebd88266c0ea5ec31641aef.pdf
work_keys_str_mv AT keshvadhedayatyanfard potentialuseofangiotensinreceptorblockersinskinpathologies
AT azadehkhalili potentialuseofangiotensinreceptorblockersinskinpathologies
AT hoseinkarim potentialuseofangiotensinreceptorblockersinskinpathologies
AT sorennooraei potentialuseofangiotensinreceptorblockersinskinpathologies
AT ehsankhosravi potentialuseofangiotensinreceptorblockersinskinpathologies
AT nazgolsadathaddadi potentialuseofangiotensinreceptorblockersinskinpathologies
AT ahmadrezadehpour potentialuseofangiotensinreceptorblockersinskinpathologies
AT gholamrezabayat potentialuseofangiotensinreceptorblockersinskinpathologies